Sunday, June 1, 2025

Latest

Medipharm Labs Closes $33.4 Million Bought Deal Financing

Medipharm Labs (TSX: LABS) has closed the bought deal financing that it announced and then later upsized earlier this week. The company managed to raise total gross proceeds of $33.4 million under the financing.

The financing saw units of the company sold at a price of $0.58, with each unit containing one common share and one common share purchase warrant. Each warrant is valid for a period of 2 years from the date of issuance at a price of $0.70 per common share.

The financing saw a total of 57.5 million units sold, while the over-allotment option was exercised in full.

Proceeds from the financing are to be used to expand the firms product portfolio, pharmaceutical registrations, R&D for clinical trials, sales and marketing, as well as working capital and general corporate purposes.

Medipharm Labs last traded at $0.49 on the TSX.


.Information for this briefing was found via Sedar and Medipharm Labs. The author has no securities or affiliations related to this organization. Not a recommendation to buy or sell. Always do additional research and consult a professional before purchasing a security. The author holds no licenses.

Leave a Reply

Video Articles

How a Single Deal Turned 2 ‘Dead’ Mines into a $2B Project | Canadian Copper PEA – Simon Quick

Silver47 x Summa Silver: Creating An Explorer With A Billion Ounce Goal

Alamos Gold Q1 Earnings: The Inside Scoop

Recommended

Silver47 x Summa Silver: Creating An Explorer With A Billion Ounce Goal

Canadian Copper: The $172M Combined Strategy PEA

Related News

Medipharm Labs: Canaccord Lowers Targets After Earnings

On August 16, Medipharm Labs (TSX: LABS) reported their second quarter financial results. The company...

Friday, August 20, 2021, 07:54:00 AM

Medipharm Labs Scrambles To Instill Investor Confidence

Medipharm Labs (TSX: LABS) appears to be scrambling to quell investor fears, releasing an update...

Thursday, January 30, 2020, 08:29:16 AM

Medipharm Labs Files Statement Of Claim Against Undisclosed Producer

Medipharm Labs (TSX: LABS) issued a typical Friday evening release today, identifying that the company...

Friday, January 24, 2020, 05:34:50 PM

Medipharm Labs Announces White Label Agreement, Provides No Details

Medipharm Labs (TSX: LABS) has entered into its second white label supply agreement with its...

Monday, May 4, 2020, 08:24:41 AM

MediPharm Labs: Canaccord Resumes Coverage, Issues $2.25 Price Target

As a follow up to the earlier covered resumption of coverage by Canaccord Genuity on...

Monday, July 6, 2020, 04:53:00 PM